Agoracom: Small Cap Investment - Resverlogix Corp. - Re: What value will be given Apabetalone for CD,...

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: What value will be given Apabetalone for CD,...

in response to

Re: What value will be given Apabetalone for CD,...

Cabel

posted on Nov 24, 2019 10:43PM

Cabel,

About a month ago, Biogen surprised everyone and announced that a new analysis of aducanumab Phase 3 trial data supports their effort to pursue regulatory filing for Alzheimer's. The details of their Phase 3s and the details of their new analysis will be presented at CTAD. Some are encouraged. Most are skeptical. We'll know in just over 10 days.

https://investors.biogen.com/news-releases/news-release-details/biogen-plans-regulatory-filing-aducanumab-alzheimers-disease

3 Recommendations

Re: What value will be given Apabetalone for CD,...

tada

Nov 25, 2019 01:22AM

Re: What value will be given Apabetalone for CD,...

tada

Nov 25, 2019 01:28AM

Re: What value will be given Apabetalone for CD,...

Cabel

Nov 25, 2019 09:50AM

Re: What value will be given Apabetalone for CD,...

KOO-KOO2

Nov 25, 2019 10:15AM

Reply New Message

Back To Forum List View

Please to post a reply